Lee Helman

Phase 0 clinical trial of the poly (ADP-ribose) polymerase inhibitor ABT-888 in patients with advanced malignancies.

Larry Rubinstein, Jerry Collins, Seth M Steinberg, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Imputation and subset-based association analysis across different cancer types identifies multiple independent risk loci in the TERT-CLPTM1L region on chromosome 5p15.33.

William Wheeler, Hideo Tanaka, Jianxin Shi, 2014, Human molecular genetics.

Phase 0 Clinical Trials: Conceptions and Misconceptions

Larry Rubinstein, Jerry Collins, James H Doroshow, 2008, Cancer journal.

Expression profiling identifies the cytoskeletal organizer ezrin and the developmental homeoprotein Six-1 as key metastatic regulators

Javed Khan, Glenn Merlino, Paul S Meltzer, 2004, Nature Medicine.

A Genome-Wide Scan Identifies Variants in NFIB Associated with Metastasis in Patients with Osteosarcoma.

David M. Thomas, Dina Halai, Sean Davis, 2015, Cancer discovery.

Genome-wide Association Study Identifies Two Susceptibility Loci for Osteosarcoma

David M. Thomas, Peter Kraft, Dina Halai, 2013, Nature Genetics.

Expression profiles of osteosarcoma that can predict response to chemotherapy.

Tsz-Kwong Man, William Meyer, Timothy Triche, 2005, Cancer research.